Company news

IQVIA Holdings, Inc. news in 2026

IQVIA Holdings, Inc.'s news releases, calls and decks from 2026, newest first.

View company

IQVIA Reports Third-Quarter 2026 Results

October 27, 2026

IQVIA Selects Veeva Clinical Operations Applications

October 13, 2026

IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

October 7, 2026

IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions

October 7, 2026

IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026

September 29, 2026

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

September 3, 2026

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

August 27, 2026

IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year

August 20, 2026

IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group

August 17, 2026

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

August 4, 2026

IQVIA Reports Second-Quarter 2026 Results

July 28, 2026

IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States

July 16, 2026

IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026

July 8, 2026

New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC

May 28, 2026

IQVIA CEO to Speak at Jefferies Global Healthcare Conference

May 26, 2026

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

May 13, 2026

Healthcare Data Monetization Research Report 2026

May 8, 2026

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

May 7, 2026

IQVIA CFO to Speak at Bank of America Health Care Conference 2026

May 6, 2026

IQVIA Reports First-Quarter 2026 Results

May 5, 2026

Pharmacovigilance and Drug Safety Software Market Report 2026 Featuring Profiles of IQVIA, Oracle Corporation, ArisGlobal, and RXLogix

April 30, 2026

IQVIA to Announce First-Quarter 2026 Results on May 5, 2026

April 15, 2026

IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

March 16, 2026

IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference

March 2, 2026

IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference

March 2, 2026

IQVIA Releases its 2025 Sustainability Report

February 27, 2026

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

February 25, 2026

IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day

February 18, 2026

IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions

February 10, 2026

IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

February 5, 2026

IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration

January 29, 2026

IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year

January 22, 2026

IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

January 20, 2026

Calls in 2026

Decks in 2026